Sample results
Non-breast cancers encompass malignancies affecting organs and tissues including ovarian, lung, prostate, and colorectal cancer. These cancers develop when abnormal cells grow uncontrollably in specific organs due to genetic mutations, environmental factors, or hormonal influences. The CA 27.29 blood test is the most important monitoring tool for tracking treatment response and disease progression in several non-breast cancer types.
Non-breast cancers are caused by genetic mutations, environmental exposures, and lifestyle factors that trigger uncontrolled cell growth in specific organs. Lung cancer often develops from tobacco smoke carcinogens and radon exposure, while colorectal cancer is linked to genetic mutations like Lynch syndrome and dietary factors. Prostate cancer is influenced by hormonal changes and age-related cellular damage, whereas ovarian cancer can result from BRCA1 and BRCA2 gene mutations or reproductive factors.
The CA 27.29 blood test is the most important monitoring tool for non-breast cancers because it detects tumor marker elevations associated with ovarian, lung, and prostate cancer activity. This test measures a protein shed by cancer cells into the bloodstream, providing valuable information about disease progression and treatment effectiveness. While not specific to a single cancer type, tracking CA 27.29 levels over time helps your healthcare team assess whether cancer treatments are working or if the disease is advancing. This blood test works best when combined with imaging studies and other diagnostic tools for comprehensive cancer monitoring.
You should get tested if you have a confirmed diagnosis of ovarian, lung, or prostate cancer and need to monitor treatment response or disease progression. Testing is also important if you notice unexplained weight loss, persistent fatigue, unusual bleeding, chronic cough, or changes in bowel or urinary habits. Regular monitoring with CA 27.29 testing helps detect cancer recurrence early and allows your medical team to adjust treatment strategies promptly when tumor marker levels rise.
What this means
Your CA 27.29 level is slightly elevated above the normal reference range. While this may warrant further investigation, elevated levels can occur for several reasons beyond cancer recurrence, including benign breast conditions or other non-cancerous causes. It's important to discuss this result with your oncologist, who will consider it alongside your medical history, physical exam, and possibly imaging studies.
Recommended actions
Contact your oncologist to discuss these results and schedule any recommended follow-up tests
Keep a record of your CA 27.29 trend over time to monitor for changes
Continue maintaining a healthy lifestyle with balanced nutrition and regular exercise
Plan to retest in 4-8 weeks or as recommended by your healthcare provider
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: